Last edition
News about "Lupin receives US FDA tentative approval for gener"
Lupin receives US FDA tentative approval for generic Briviact tablets
Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) brivaracetam tablets
Lupin Receives US FDA Tentative Approval For Gener | 17/08/2021 | By Darshana | 144
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members